Feb. 25, 2023

baxdrostat

oral aldosterone synthase (CYP11B2) inhibitor Ph. I/II for HTN, CKD, primary aldosteronism from in-house screen of aldosterone synthase inhibitors Press release, January 9, 2023 Roche, Basel, CH (Cincor/AstraZeneca)

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in